High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.

In a single centre, 52 newly diagnosed patients with acute myeloid leukemia (AML) under the age of 56 years received induction chemotherapy commencing with high-dose cytosine arabinoside (Ara-C) and etoposide (Protocol BF11), followed by Ara-C, 6 thioguanine (6TG). A total of 67% of patients entered...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Parikh, P., Powles, R., Treleaven, J., Helenglass, G., Gore, M., Rose, M., Talbot, D., Milan, S., Smith, C., Pinkerton, R.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1990
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971542/
https://ncbi.nlm.nih.gov/pubmed/2245176
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki